Skip to main content

Table 3 Mean (Standard Deviation) of PROs at baseline and week 12, and change from baseline to week 12

From: The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study

Measure Baseline Week 12 Change1
DLQI Total Score 12.71 (7.18) 5.28 (6.49) -7.45 (7.78)
SF-36    
   Physical Functioning 79.26 (24.95) 84.43 (22.62) 5.63 (22.25)
   Role-Physical 72.45 (37.56) 82.50 (34.67) 9.64 (40.30)
   Bodily Pain 59.58 (25.37) 75.87 (24.89) 16.59 (26.90)
   General Health 66.7 (20.6) 72.69 (20.79) 6.10 (16.25)
   Vitality 53.89 (22.81) 61.04 (23.18) 7.60 (20.88)
   Social Functioning 74.49 (27.56) 85.98 (23.63) 11.16 (27.80)
   Role-Emotional 76.03 (35.39) 85.48 (30.77) 8.39 (37.02)
   Mental Health 69.39 (19.30) 77.43 (17.73) 8.14 (18.57)
   Physical Summary Score (PCS) 47.93 (10.23) 51.24 (9.51) 3.47 (9.30)
   Mental Summary Score (MCS) 47.30 (11.23) 51.36 (10.08) 3.94 (11.04)
EQ-5D    
   Index Score 0.66 (0.28) 0.82 (0.23) 0.16 (0.29)
   VAS Overall Health 72.25 (20.67) 81.22 (17.26) 9.35 (20.71)
  1. 1Change scores are computed only for patients with scores at baseline and Week 12; this number varied between 138 and 140, depending on the specific measure, as compared with the 147 patients at baseline.